Roche could top Pfizer, Lilly by 2014
While Pfizer, Eli Lilly, J&J, GlaxoSmithKline and Sanofi-Aventis face expiring patents and a sizeable drop in rank in the coming years, Roche might hold strong and is poised to carry about 6 percent of the global prescription drug market in 2014. Ranked fifth in 2007, the company is also less at risk of losing revenue to genetic competitors. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
